Pfizer Price Targets? I've Got Them for You
A subscriber asks. We answer.
Veru Is Pointed Lower Now
Charts suggest there could be further downside risk.
Jim Cramer: Let's Give Taiwan a Needed Shot in the Arm
Here's how the U.S. can play a critical part in defending the island from COVID -- and mainland China.
Is Pfizer Ready to Make an Upside Breakout?
Traders could go long PFE at current levels and here's where they can add to longs.
GoodRx Isn't Showing Us a Good Stock Chart
Avoid the long side of GDRX until we see evidence of a durable bottom.
A 5-Stock Healthcare Portfolio With a 5.5% Yield
These names offer appeal to both growth and dividend investors.
How Do the 11 S&P Sectors Look Technically?
The sector ETFs present a different picture than the broader averages.
Intellia Therapeutics Busts Out of Resistance on Positive Trial News
The news sent shares of the genome editing company skyward after the stock had been basing for months.
Uncertain Fiscal Policy, FOMC, Virus X Factor, Copper, United Rentals Stock
There's a split growing at the FOMC as to just how transitory the current burst of consumer level inflation actually is.
Sesen Bio Is a Low Priced Stock With Good Technical 'Bones'
Let's review the charts and indicators.